The invention provides specific peptides derived from the cytotoxicity receptor NKp44 useful for preventing and treating serious diseases including in particular cancer. The invention further relates to compositions comprising a fragment of the extracellular region of NKp44 for preventing or treating cancer.

Original languageEnglish
Patent numberUS2015105334
IPCC07K 7/ 08 A I
Priority date22/09/14
StatePublished - 16 Apr 2015


Dive into the research topics of 'PEPTIDES DERIVED FROM NKP44'. Together they form a unique fingerprint.

Cite this